Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lucid Scientific
Atlanta, Georgia, United Stateslucidsci.com ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Commercial
01
Overview
Lucid Scientific commercializes the Resipher system—a real-time, non-invasive oxygen consumption rate monitoring device for cell cultures. It enables continuous metabolic analysis in standard 96-well plates and streams data to a web app for researchers.
- Modalities
- DeviceBiosensor (for cell culture monitoring)
- Industry
- Drug Discovery Services
02
Partnerships
Early-access program with top academic and industry researchers for Resipher evaluation
Beyond the preview
Go deeper on Lucid Scientific.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lucid Scientific.